Delivery Order SPE2DR25D3103-SPE2DR26F0E2L
Award Date 2/25/26
Potential Completion Date 3/18/26
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $1,009.30 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for ZOLADEX 10.8 MG implant syringes, with an ultimate completion date of March 3, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside used.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Zoladex 3.6 mg implant syringes, with a ceiling value of $2,155.68 and an ultimate completion date of February 27, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was issued on a firm fixed price basis with no set-aside.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 26, 2026, for Zoladex 3.6 mg implant syringes with a ceiling value of $2,155.68.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is March 19, 2026. The order was priced on a firm fixed-price basis and used no set-aside.</p>
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,648.75 to AmerisourceBergen Drug Corp for ZOLADEX 10.8 MG implant syringes, with performance in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on July 1, 2025, represents completion by July 23, 2025. The contract was competitively awarded with no set-aside designation, demonstrating AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements through open competition. This...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 10, 2026, for Zoladex 10.8 mg implant syringes with a ceiling value of $18,167.40. Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical IDC, a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Ultimate completion date is March...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of ZOLADEX 3.6 MG Implant Syringes at a firm fixed price of $2,092.74, with an ultimate completion date of November 24, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Zoladex 10.8 mg implant syringes with a ceiling value of $6,055.80 under a firm fixed-price arrangement.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for Zoladex 10.8 mg implant syringes, with a ceiling value of $2,018.60 and ultimate completion date of March 2, 2026.</p> <p>The order is issued under Amerisourcebergen's parent Indefinite Delivery Contract with DLA Troop Support Medical, a global pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA.</p>
- The Defense Logistics Agency awarded a $3,592.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ZOLADEX 3.6 MG implant syringes, with an ultimate completion date of February 13, 2026. This non-set-aside contract was awarded competitively on January 23, 2026, with performance to be executed from the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major...
- The Defense Logistics Agency (DLA) awarded a $8,772.80 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of 4565703763 ZOLADEX 10.8 MG IMPLANT SYRNS. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which enables the agency to efficiently procure a range of essential medical commodities from Amerisourcebergen to...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F0E2LDelivery Order
The Defense Logistics Agency issued a $24,223.20 delivery order to Amerisourcebergen Drug Corp on February 25, 2026, for ZOLADEX 10.8 MG implant syringes. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 18, 2026. No set-aside was used.
Generated 5/27/26, 10:48 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.2k | 2/24/26 |